TITLE:
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

CONDITION:
Non-small Cell Lung Cancer

INTERVENTION:
TLK286, cisplatin

SUMMARY:

      The purpose of this trial is to study the efficacy and safety of the combination of TLK286
      with cisplatin as first-line therapy for patients with locally advanced or metastatic
      non-small cell lung cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  18 years of age or older

          -  Histologically confirmed non-small cell lung cancer

          -  Stage IV or IIIB

          -  Measurable disease by RECIST

          -  ECOG performance status of 0-1

          -  Adequate liver and renal function

          -  Adequate bone marrow reserve

        Exclusion Criteria:

          -  History of bone marrow transplantation or stem cell support

          -  Pregnant or lactating women
      
